Most Read Articles
Popular Stories
RADAR on Medicare Advantage
-
As major publicly traded insurers reported third-quarter 2024 earnings results in recent weeks, familiar issues continued to impact select government players. For one, Medicaid managed care organizations are still...
-
Even as 2025 shapes up to be a year of service area reductions and product reshuffles, Medicare Advantage insurers are still making big investments in Special Needs Plans (SNPs). There are 137 net new...
HEALTH PLAN WEEKLY
-
Alignment Healthcare, Inc., Clover Health Investments Corp. and Oscar Health, Inc., which are commonly referred to as “insurtechs” for their focus on technology, each recently posted solid third-quarter...
-
CVS Health Corp.’s third-quarter 2024 earnings call — which it held on the same morning when many Americans woke up to learn Donald Trump had won the presidency — focused largely on how the firm’s...
Radar On Speciality Pharmacy
-
In the seven years since the approval of the first chimeric antigen receptor T-cell (CAR-T) therapy, the agents have proved to be effective in the treatment of non-Hodgkin lymphoma. But the one-time-use agents...
-
Recently publicized data from a late-stage clinical trial for an HIV pre-exposure prophylaxis (PrEP) therapy showed promise for twice-yearly treatments, potentially boosting compliance, according to industry...
RADAR ON DRUG BENEFITS
-
On the same day that the Biden administration proposed a rule that would require health insurers to cover over-the-counter birth control, it released a less-heralded guidance document that makes another...
-
Only 27% of stand-alone Medicare Part D Prescription Drug Plans (PDPs) — or 11 contracts — earned 4 stars or higher for the 2025 plan year, according to CMS’s 2025 Medicare Advantage and Part D Star Ratings...
About AIS Health
AIS Health is a publishing and information company that has served the health care industry for more than 30 years. Our mission is to provide our readers with an actionable understanding of the business of health care and pharmaceuticals. Our in-depth writing covers the companies, people, catalysts and trends that create the richly textured contours of the health care and drug industry. AIS Health maintains journalistic independence from our parent company, MMIT. We are committed to integrity in reporting and bringing transparency to health industry data.
The Latest
Premium Categories
Premium Categories
Meet Our Reporters
Meet Our Reporters
Get an actionable understanding of the business of health care and pharmaceuticals
Sign up for publications to get unmatched business intelligence delivered to your inbox.